Prothena
PRTA
#7748
Rank
NZ$0.80 B
Marketcap
NZ$15.77
Share price
2.67%
Change (1 day)
-12.76%
Change (1 year)

Earnings for Prothena (PRTA)

Earnings in 2026 (TTM): -NZ$0.11 Billion

According to Prothena's latest financial reports the company's current earnings are NZ$54.53 Million. In 2025 the company made an earning of -NZ$0.33 Billion a decrease over its 2024 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prothena from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.11 Billion-68.5%
2025 -NZ$0.33 Billion19.41%
2024 -NZ$0.28 Billion-19.09%
2023 -NZ$0.35 Billion45.21%
2022 -NZ$0.24 Billion-282.78%
2021 NZ$0.12 B-163.84%
2020 -NZ$0.21 Billion33.94%
2019 -NZ$0.16 Billion-44.78%
2018 -NZ$0.28 Billion-0.97%
2017 -NZ$0.28 Billion-3.33%
2016 -NZ$0.29 Billion99.17%
2015 -NZ$0.15 Billion1102.24%
2014 -NZ$11.86 Million-83.55%
2013 -NZ$72.11 Million-2.37%
2012 -NZ$73.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amarin Corporation
AMRN
-NZ$45.59 Million-57.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
NZ$2.00 B-1,978.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$0.42 B-496.21%๐Ÿ‡ฎ๐Ÿ‡ช Ireland